Association between cigar use, with and without cigarettes, and incident diagnosed COPD: a longitudinal cohort study
- PMID: 38178199
- PMCID: PMC10765880
- DOI: 10.1186/s12931-023-02649-2
Association between cigar use, with and without cigarettes, and incident diagnosed COPD: a longitudinal cohort study
Erratum in
-
Correction to: Association between cigar use, with and without cigarettes, and incident diagnosed COPD: a longitudinal cohort study.Respir Res. 2024 Feb 23;25(1):98. doi: 10.1186/s12931-024-02728-y. Respir Res. 2024. PMID: 38395917 Free PMC article. No abstract available.
Abstract
Background: While regular cigar smoking is believed to carry similar health risks as regular cigarette smoking, the impact of cigar use, alone or in combination with cigarettes, on obstructive pulmonary disease (COPD) has not been well characterized. The purpose of this study was to examine the prospective association between exclusive and dual cigar and cigarette use and incident self-reported diagnosed COPD.
Methods: This study used data from Waves 1-5 (2013-2019) of the Population Assessment of Tobacco and Health (PATH) Study, a nationally representative survey of U.S. adults. Longitudinal data from adults aged 40 to 79 at Wave 1, without a pre-existing COPD diagnosis who participated at follow-up interview were analyzed. A time-varying current tobacco exposure, lagged by one wave and categorized as: (a) never/non-current use; (b) exclusive cigar use; (c) exclusive cigarette use; and (d) dual cigar/cigarette use. Multivariable models adjusted for demographics (age, sex, race or ethnicity, education), clinical risk factors (asthma, obesity), and smoking-related confounders (second-hand smoke exposure, other combustible tobacco product use, e-cigarette use, time since quitting, cigarette pack-years). The incidence of self-reported diagnosed COPD was estimated using discrete-time survival models, using a general linear modeling (GLM) approach with a binomial distribution and a complementary log-log link function.
Results: The analytic sample consisted of 9,556 adults with a mean (SD) age of 56 (10.4), who were predominately female (52.8%) and Non-Hispanic White (70.8%). A total of 906 respondents reported a diagnosis of COPD at follow-up. In the fully adjusted model, exclusive cigar use (adjusted hazard ratio (aHR) = 1.57, 95% CI: 0.77, 3.21) was not associated with increased COPD risk compared to non-use, while exclusive cigarette use (aHR = 1.48, 95% CI: 1.13, 1.93) and dual cigar/cigarette use (aHR = 1.88, 95% CI: 1.24, 2.85) were.
Conclusions: Exclusive cigarette use and dual cigar/cigarette use were associated with diagnosed incident COPD. These results suggest that cigars, when used in combination with cigarettes, may be associated with poorer COPD health outcomes. Dual use may promote a higher likelihood of inhaling cigar smoke, and future research would benefit from examining whether inhalation of cigar smoke increases COPD risk.
Keywords: COPD; Cigarettes; Cigars; Health effects.
© 2023. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Similar articles
-
Association of tobacco product use with chronic obstructive pulmonary disease (COPD) prevalence and incidence in Waves 1 through 5 (2013-2019) of the Population Assessment of Tobacco and Health (PATH) Study.Respir Res. 2022 Oct 1;23(1):273. doi: 10.1186/s12931-022-02197-1. Respir Res. 2022. PMID: 36183112 Free PMC article.
-
Respiratory symptoms and outcomes among cigar smokers: findings from the Population Assessment of Tobacco and Health (PATH) study waves 2-5 (2014-2019).Respir Res. 2024 Apr 27;25(1):185. doi: 10.1186/s12931-024-02818-x. Respir Res. 2024. PMID: 38678212 Free PMC article.
-
Longitudinal association of exclusive and dual use of cigarettes and cigars with asthma exacerbation among US adults: a cohort study.Respir Res. 2024 Aug 10;25(1):305. doi: 10.1186/s12931-024-02930-y. Respir Res. 2024. PMID: 39127698 Free PMC article.
-
Health impact of e-cigarettes and heated tobacco products in chronic obstructive pulmonary disease: current and emerging evidence.Expert Rev Respir Med. 2022 Nov-Dec;16(11-12):1213-1226. doi: 10.1080/17476348.2023.2167716. Epub 2023 Jan 22. Expert Rev Respir Med. 2022. PMID: 36638185 Review.
-
Immunology in COPD and the use of combustible cigarettes and heated tobacco products.Eur J Med Res. 2023 Oct 4;28(1):397. doi: 10.1186/s40001-023-01374-2. Eur J Med Res. 2023. PMID: 37794516 Free PMC article. Review.
Cited by
-
Correction to: Association between cigar use, with and without cigarettes, and incident diagnosed COPD: a longitudinal cohort study.Respir Res. 2024 Feb 23;25(1):98. doi: 10.1186/s12931-024-02728-y. Respir Res. 2024. PMID: 38395917 Free PMC article. No abstract available.
-
Prevalence and Socioeconomic Disparities of Cigar Use in China: Findings from the China Health Literacy Survey with a Focus on the 'Knowledgeable but Economically Marginalized' (KEM) Population.Healthcare (Basel). 2025 Mar 7;13(6):583. doi: 10.3390/healthcare13060583. Healthcare (Basel). 2025. PMID: 40150433 Free PMC article.
-
The Public Health Impact of a Ban on Flavored Cigars: A Decision-Theoretic Policy Framework.Nicotine Tob Res. 2025 Jan 22;27(2):333-341. doi: 10.1093/ntr/ntae173. Nicotine Tob Res. 2025. PMID: 39001665 Free PMC article.
References
-
- National Academies of Sciences E., Medicine. Premium Cigars: Patterns of Use, Marketing, and Health Effects. 2022. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical